Francis Willard Sarena

Filings by Francis Willard Sarena span 3 companies, the busiest being Five Prime Therapeutics Inc, 89bio, Inc. and Apexigen, Inc. In total, 21 filings cover trades dated from 27 January 2016 to 30 October 2025.

The open-market record consists of 6 sales, with no purchase. No amount is published for 6 filings, which the totals therefore leave out. The rest of the record consists of 9 share grants and 5 option exercises.

Most recently, on 30 October 2025, the filings show a transaction in 89bio, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.